Comment to: Development of lens opacities with peculiar characteristics in patients affected by thalassemia major on chelating treatment with deferasirox. Haematologica 2008;93:e9-10

Haematologica. 2008 Jun;93(6):e49; discussion e50. doi: 10.3324/haematol.12944.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzoates / adverse effects*
  • Benzoates / therapeutic use
  • Cataract / chemically induced*
  • Deferasirox
  • Humans
  • Iron Chelating Agents / adverse effects*
  • Iron Chelating Agents / therapeutic use
  • Research Design
  • Sample Size
  • Triazoles / adverse effects*
  • Triazoles / therapeutic use
  • beta-Thalassemia / drug therapy*

Substances

  • Benzoates
  • Iron Chelating Agents
  • Triazoles
  • Deferasirox